Ozempic numbers are shown for a 1 mg dose, but Novo complains that the FDA approved a higher, more effective maintenance dose of Ozempic (2 mg) more than four years ago. In short, the Novo Nordisk lawsuit alleges that Lilly has been using intentionally selected outdated studies that compare Lillys highest doses against lower doses of Novo Nordisk's medicines, deceptively presenting those results as proof of broad, product-level superiority while burying or omitting critical clinical context. Lilly contends that its ads are citing the only head-to-head studies that have been conducted
Such aspects, and much more including glutathione-boosting substances administrable to humans, are considered in this state-of-the-art review, which deals with glutathione and glutathione-dependent enzymes from biochemistry to gerontology, focusing attention also on lifespan/healthspan extension and successful aging
On the other hand, Luthi et al
Unusual case of gastroparesis leading to severe gastromegaly with demyelinating disease as a rare cause
In the medical field the use of acetyl L-carnitine and propionyl L- carnitine is already known
